Альфа-пвп: описание и особенности

Alpha-PVP crystals often have sharp edges and varying sizes. Alpha-PVP and its metabolites can be detected in blood and urine postmortem.

Common clinical symptoms include mydriasis (dilated pupils), diaphoresis (excessive sweating), and seizures. It acts as a psychostimulant with properties similar to cocaine and MDMA.

User reports indicate a transition from initial euphoria to distress and anxiety is common. Common street names for Alpha-PVP include 'flakka', 'gravel', and 'niff'.

It was placed under a temporary nationwide ban in the United States effective February 2014.

Intranasal administration leads to effects appearing within minutes, lasting approximately 3 hours. Strong compulsive desire for re-dosing is a reported characteristic of Alpha-PVP use.

Its mechanism involves inhibiting the reuptake of dopamine (DAT) and norepinephrine (NET), leading to increased synaptic concentrations. Clinical manifestations of intoxication often include tachycardia (observed in 92% of cases in one study), hypertension, and hyperthermia.

The onset of effects can be subtle or delayed, which may lead to accidental overdosing due to re-dosing. The visual presentation is typically a loose structure of particles on a neutral background.

Alpha-PVP is classified as a synthetic cathinone, part of the 'bath salts' family of designer drugs.

Alpha-PVP is not explicitly scheduled under New Zealand's Misuse of Drugs Act but is controlled via structural similarity provisions. Alpha-PVP is more potent than methamphetamine in some rat self-administration studies when compared to MDPV, but less potent than methamphetamine in substitution tests.

Alpha-PVP (alpha-pyrrolidinovalerophenone) is a synthetic cathinone stimulant. Media reports claiming Alpha-PVP causes 'superhuman strength' or specific bizarre behaviors in all users are often sensationalized and not universally supported by clinical data.

Alpha-PVP is typically found in the form of crystals or capsules. The 'Causeway Cannibal' case was initially linked to bath salts but later forensic evidence did not definitively confirm this link.

Visual appearance often includes small white or bluish translucent crystals with a shiny surface.

Alpha-PVP acts primarily as a norepinephrine-dopamine reuptake inhibitor (NDRI), with weaker effects on serotonin transporters. The European Union banned Alpha-PVP in 2015.

It is a molecular analogue of pyrovalerone and structurally related to MDPV (methylenedioxypyrovalerone). Rhabdomyolysis (muscle breakdown) has been reported in approximately 15% of clinical cases studied.

Conformational restriction of the structure (e.g., in aminotetralone derivatives) leads to lower efficacy compared to Alpha-PVP. The duration of high is approximately 3–5 hours for most routes of administration.

The substance was marketed as 'legal highs' before being banned in many regions.